Clinical Trial Update: SARS Survivor Evaluations

View source ↗

Summary

A clinical trial evaluating SARS survivors (SARS-CoV) has been withdrawn by its sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Coronavirus (SARS-CoV) | Status: WITHDRAWN